Because real people deserve great lawyers.
For decades we have helped clients and referring attorneys get the results they want and deserve – at trial and in settlements. We are leaders in drug and medical device litigation and have helped thousands of medical negligence, personal injury and accident victims across the country find justice. Our trial lawyers are smart, prepared, tenacious and by your side all the way.
Let’s talk.
If you would like to know more about representation or have one of our experienced attorneys provide a complimentary evaluation of your case, call us at 214.761.6614.
Latest News Articles
News
Ben Martin Law Group Chosen for 2025 List of Best Law Firms
Dallas-based personal injury firm earns repeat honors DALLAS – The Ben Martin Law Group has once again earned a place on the Best Law Firms listing of the top practices in the Dallas-Fort Worth metro area. Firm founder and veteran trial lawyer Ben C. Martin was recently recognized by the Best Lawyers in America legal…
Depo-Provera, Depo-SubQ Provera, and an Authorized Generic Version Linked to Increased Risk of Meningioma—You May Be Entitled to Compensation
A recent study, “Use of Progestogens and the Risk of Intracranial Meningioma: National Case-Control Study,” published in The British Medical Journal (BMJ) — one of the world’s most trusted medical journals—has uncovered a concerning link between Depo-Provera, a popular birth control shot, and a higher risk of developing meningioma, a type of brain tumor. The…
Wrongful Death & Catastrophic Injury
Ben Martin Law Group Attorneys Secure $18M Award for Survivors of 2020 Crash
Three family members suffered lasting health issues in traffic accident DALLAS – Attorneys with the Dallas-based personal injury firm Ben Martin Law Group recently helped a family secure an $18 million jury award stemming from a two-vehicle accident on Dec. 26, 2020. The plaintiffs John Patrick Scott, 68, Kathryn Scott, 68, and their son, John…
CBS 11 I-Team speaks with Ben Martin Law Group over KCS Railway Negligence in Railroad Crossing Death.
Brian New of CBS I-Team spoke with attorney Ben Martin regarding the neglect and liability of Kansas City Southern Railway in the death of Sue Rigsby, who died after a train collided with her vehicle at a railroad crossing in Campbell, Texas. It has been more than four years since the substandard crossing claimed the…
IVC Filter Complications
Ben Martin Law Group Trial Lawyers Earn Top Verdict Honors for 2021 IVC Filter Litigation
Dallas trial firm stands out for successes in medical device defect litigation DALLAS – A $2.549 million jury verdict over a defective medical device secured by Ben Martin Law Group has been recognized as one of the state’s top 100 verdicts for 2021, according to an analysis by Texas Lawyer magazine and VerdictSearch. The May 2021 verdict…
Law Firm Honored as National Law Journal’s Elite Trial Lawyers Finalists
National award based on 2021 work in mass tort litigation DALLAS – Dallas-based Martin Baughman (now Ben Martin Law Group) was named 2022 finalist for the National Law Journal’s Elite Trial Lawyers honors for mass tort litigation based on the firm’s string of jury verdicts and settlements on behalf of individuals injured by defective medical…
Transvaginal Mesh
Victims get nothing from Texas’s $8.8 million settlement with pelvic mesh manufacturer
Ben Martin Law Group and their client Jennifer Snowden are committed to spreading the word to women regarding the devastating pain and suffering that pelvic mesh products cause. Unfortunately, the fact that some transvaginal mesh products are still on the market does not mean they are safe. The FDA does not test or study these…
Problems With Transvaginal Surgical Mesh
Transvaginal surgical mesh procedures have become problematic. These procedures include implanting a synthetic or biological material in order to repair weakened or damaged tissue and organs, often in a woman’s pelvic area. The diagnosis is typically referred to as pelvic organ prolapse (“POP”), or stress urinary incontinence (“SUI”). In 2008, the FDA issued a Public…